Tradestie Institutional Equity Comparison Engine
BBNX vs DCTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DCTH Overall Edge
DCTH Captures Institutional Edge (4โ0 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BBNX trades at N/M Forward P/E with -72.8% operating margin (+30.3% YoY revenue) versus DCTH at N/M Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, BBNX sits in CONSOLIDATION (54th %ile IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
DCTH
BBNX N/M vs DCTH N/M Fwd P/E
Growth & Margin Winner
DCTH
Op Margin -72.8% vs 5.2% ยท YoY +30.3% vs +70.7%
Momentum & Technical Winner
DCTH
1Y -40.5% vs +128.6% ยท 52W Pos 28% vs 80%
Options & Structure Winner
DCTH
CONSOLIDATION (54th %ile IV) vs BREAKOUT (43rd %ile IV)
BBNX
NASDAQ
Beta Bionics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$15.60
-4.99% 1D
Market Cap
$897.6M
1M Return
-4.59%
1Y Return
-40.55%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 51.0
Fund 59.0
Flow 57.0
Mom 50.0
DCTH
NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap
$743.8M
1M Return
+39.77%
1Y Return
+128.57%
Forward P/E
N/M
Unified AI Score
35.9 / 100
SELL
Tech 50.0
Fund 38.0
Flow 60.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BBNX -40.55%
DCTH +128.57%
Spread: +169.12 pp (DCTH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BBNX Revenue | DCTH Revenue | BBNX Op. Margin | DCTH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2013 | N/A | $0M | N/A | -4179.6% | DCTH |
| FY2014 | N/A | $0M | N/A | -1805.8% | DCTH |
| FY2015 | N/A | $0M | N/A | -870.6% | DCTH |
| FY2021 | N/A | $0M | N/A | -690.0% | DCTH |
| FY2022 | N/A | $0M | N/A | -1245.1% | DCTH |
| FY2023 | $10M | $0M | -298.9% | -1849.0% | BBNX |
| FY2024 | $70M | $40M | -69.5% | -33.4% | DCTH |
| FY2025 | $100M | $90M | -71.5% | 0.8% | DCTH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BBNX | DCTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $897.6M | $743.8M | Larger Scale | BBNX |
| Trailing P/E Ratio Valuation | N/M | 133.6x | Lower Multiple | DCTH |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +30.3% | +70.7% | Higher Growth | DCTH |
| Operating Margin (TTM) Profitability | -72.8% | 5.2% | Higher Margin | DCTH |
| Net Profit Margin Profitability | -65.3% | 6.0% | Higher Margin | DCTH |
| Return on Equity (ROE) Capital Efficiency | -23.9% | 5.4% | Higher ROE | DCTH |
| 52-Week Range Position Momentum | 28% ($9โ$33) | 80% ($8โ$23) | Stronger Trend | DCTH |
| Beta / 30D Volatility Risk Regime | 1.83ฮฒ ยท 108% Vol | 1.63ฮฒ ยท 131% Vol | Lower Realized Risk | BBNX |
| Unified Institutional Score Composite Signal | 52.1 / 100 (HOLD) | 35.9 / 100 (SELL) | Higher Composite | BBNX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BBNX vs DCTH Buy Guide
BBNX
CONSOLIDATION
84d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
54th %ile
IV Regime
Balanced (25thโ60th %ile)
DCTH
BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
43rd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BBNX nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.